RecruitingNot ApplicableNCT05114798

Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers

Effects of Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers Among Adults With Obesity


Sponsor

University of Illinois at Chicago

Enrollment

255 participants

Start Date

May 17, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Approximately 42% of American adults are obese, and this condition is strongly related to the development of colorectal cancer. Innovative lifestyle strategies to treat obesity and reduce colorectal cancer risk are critically needed. This research will demonstrate that time-restricted eating, a type of intermittent fasting, is an effective therapy to help obese individuals reduce and control their body weight and prevent the development of colorectal cancer.


Eligibility

Min Age: 45 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This trial is comparing two approaches to losing weight and reducing colon cancer risk: time-restricted eating (eating only within a set window of hours each day) versus daily calorie counting and restriction. Being overweight is a known risk factor for colorectal cancer, and this study looks at which approach better reduces both weight and cancer-related markers in the body. **You may be eligible if...** - You are 45–70 years old - You have a body mass index (BMI) between 30 and 49.99 (obese range) - You are up to date with colorectal cancer screening - You are not currently on a formal weight loss program - Your weight has been stable for the past 3 months (no more than ~4 kg gained or lost) **You may NOT be eligible if...** - You have kidney disease, autoimmune disorders, serious digestive or liver disease, eating disorder, or have had bariatric (weight loss) surgery - You drink heavily, use tobacco, or have poorly controlled diabetes (HbA1c above 9%) - You have had cancer treatment in the past year, have colorectal cancer, or have a genetic predisposition like Lynch syndrome - You work night shifts or are pregnant/trying to become pregnant - Your weight exceeds 450 lbs (DXA scan limit) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALTime restricted eating

daily ad libitum food intake, 8-h 12pm - 8pm, 6 m active weight loss phase; 10-h 10am-8pm, 6 m maintenance phase

BEHAVIORALCalorie Restriction

daily 25% calorie restriction, 6 m active weight loss phase; 100% energy needs, 6 m maintenance phase


Locations(1)

University of Illinois at Chicago

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05114798


Related Trials